Moleculin Biotech Inc (MBRX)
2.45
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
2.43
-0.02
(-0.82%)
After-Hours: 20:00
Moleculin Biotech Cash from Financing (Quarterly): -0.025M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.025M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 4.465M |
| September 30, 2023 | -0.004M |
| June 30, 2023 | 0.049M |
| March 31, 2023 | 0.141M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.011M |
| June 30, 2022 | -0.012M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.024M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 74.75M |
| December 31, 2020 | 5.484M |
| September 30, 2020 | 1.762M |
| June 30, 2020 | 10.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.291M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.052M |
| June 30, 2019 | 15.28M |
| March 31, 2019 | 5.521M |
| December 31, 2018 | 1.761M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 2.069M |
| March 31, 2018 | 8.215M |
| December 31, 2017 | 1.384M |
| September 30, 2017 | 1.083M |
| June 30, 2017 | 2.327M |
| March 31, 2017 | 5.265M |
| December 31, 2016 | 0.003M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 8.31M |
| March 31, 2016 | 0.552M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.025M
Minimum
Jun 2024
74.75M
Maximum
Mar 2021
5.362M
Average
--
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| Agilent Technologies Inc | -246.00M |
| Seelos Therapeutics Inc | 0.742M |
| Cara Therapeutics Inc | -0.61M |
| Citius Pharmaceuticals Inc | 13.72M |
| NovaBay Pharmaceuticals Inc | -0.492M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.949M |
| Cash from Investing (Quarterly) | -0.013M |
| Free Cash Flow | -25.75M |
| Free Cash Flow Per Share (Quarterly) | -2.344 |
| Free Cash Flow Yield | -468.3% |